An in-depth analysis of two common treatments for advanced pancreatic cancer from The University of Toledo has found the combination chemotherapy drug Folfirinox is more likely to promote progression-free survival—a notable ...
Feb 8, 2024
0
2
Directed by Laura Soucek, an ICREA Research Professor, Director of VHIO's Experimental Therapeutics Program and head of our Models of Cancer Therapies Group, two decades of research aimed at combating resistance to therapy ...
Feb 7, 2024
0
1
Italian scientists from Università Cattolica at Rome have discovered an important genetic mechanism that pancreatic cancer cells employ to evade therapies, paving the way to new drugs for a killer disease. The tumor evades ...
Feb 6, 2024
0
137
The U.S. Food and Drug Administration (FDA) has awarded Orphan Drug Designation to Canget BioTekpharma LLC for FL118, a drug candidate developed at Roswell Park Comprehensive Cancer Center, as a possible treatment for pancreatic ...
Feb 5, 2024
0
0
Pancreatic cancer is the No. 3 cause of cancer-related deaths in the United States, and only 12% of patients survive five years after being diagnosed. Severe pancreatic cancer is associated with metastasis, and it is this ...
Feb 3, 2024
0
59
Pancreatic cancer can be a devastating diagnosis due to its extremely aggressive nature and low survival rate. But there may be hope on the horizon thanks to scientists at RUSH who have discovered two new targets for decreasing ...
Feb 1, 2024
0
25
Overweight and obesity are contributing to rising death rates from bowel cancer among people aged 25–49 years in the European Union (EU) and the UK, although death rates from this type of cancer are decreasing overall across ...
Jan 28, 2024
0
20
Unintentional weight loss is associated with an increase in the risk of a cancer diagnosis within the coming year, according to a study from Dana-Farber Cancer Institute.
Jan 23, 2024
0
43
Cedars-Sinai Cancer investigators have used a unique precision medicine and artificial intelligence (AI) tool called the Molecular Twin Precision Oncology Platform to identify biomarkers that outperform the standard test ...
Jan 22, 2024
0
55
Pancreatic cancer is known as a 'silent killer' because it's usually only detected in its later stages.
Jan 18, 2024
0
0
